Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 583.30
+1.45 (0.25%)
Dec 19, 2025, 3:29 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 140.84 billion as of December 19, 2025. Its market cap has decreased by -2.28% in one year.
Market Cap
140.84B
Enterprise Value
152.72B
Revenue
48.42B
Ranking
n/a
PE Ratio
27.46
Stock Price
583.30
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 140.84B, an increase of 85,938.39%. That is a compound annual growth rate of 34.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 140.84B | -1.78% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | 87.22B | 178.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 1.68T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.01T |
| Zydus Lifesciences | 920.05B |
| Mankind Pharma | 869.37B |
| Aurobindo Pharma | 684.24B |
| Alkem Laboratories | 677.16B |